US pharmacy said they can compound 10 mg. What should it cost?

We will not quote a compounded Motilium dollar. Domperidone is not FDA-approved, and FDA has warned against compounding it for lactation. If a specialist is using a lawful pathway for a GI indication, that clinic and that pharmacy own the price and the monitoring. A letters desk that invents a coupon is doing the thing this lock forbids. Ask for the ECG plan, not for a discount code.

Can I take 10 mg four times daily like older Motilium leaflets?

Not on current EU labelling. The post-2014 adult oral lock is 10 mg up to three times daily, 30 mg/day. Some older non-EU sheets still mention 40 mg. Epidemiology put extra cardiac risk above 30 mg/day. Do not rebuild a 2010 leaflet. If nausea survives a week at 30 mg, the next step is diagnosis, not a fourth tablet.

I am 64 with a normal ECG last year. Still a problem?

Age over 60 is a named higher-risk group. A year-old ECG does not clear today's electrolytes or this week's azithromycin. EU language asks people over 60 to consult a clinician before Motilium. Bring the full medicine list, including grapefruit habit. Syncope or new palpitations on the tablet: stop and seek care. We do not clear ECGs from a PDF in an email.

Lactation consultant in Canada suggested 10 mg TID. Safe milk plan?

Domperidone is not authorised to promote lactation in Canada or anywhere else. Off-label use exists. Cardiac risk and psychiatric withdrawal after abrupt high-dose stops are the regulator notes. Typical published regimens were 10 mg TID for several days; higher doses did not clearly help non-responders in small studies. This desk will not write a pumping schedule or a wean. That conversation stays with the clinician who proposed it. QT and milk postscript .

On clarithromycin for a week. Start Motilium for the erythromycin-level nausea?

No. Clarithromycin is a macrolide CYP3A4 inhibitor and a QT drug. Co-administration with potent CYP3A4 inhibitors is contraindicated. Treat the nausea with something that does not share that stop, or revisit the antibiotic. Stacking Motilium onto clarithromycin is the interaction the 2014 cut was built to prevent.

I missed the lunch dose and vomited dinner. Take 20 mg now?

Skip the missed tablet. Do not double. If vomiting is that active, you need a clinician, not a catch-up stack. Oral Motilium assumes you can keep a tablet down. Persistent vomiting, abdominal rigidity, or blood in the basin is an emergency department problem. A second 10 mg an hour later is not a labelled rescue.

Is Motilium safer than metoclopramide because it stays out of the brain?

It is more peripherally selective, which is why acute dystonia is less the Motilium story. Prolactin still rises. QT is the Motilium story. Metoclopramide's long-use tardive risk is real and is why many labels cap duration. Safer is the wrong word. Different harm profiles. Neither is a US Motilium cash fill, and metoclopramide is a different letter we have not opened here.

EBay blister says Motilium 10 mg x 100 for gastroparesis. Use it?

We will not validate a marketplace blister. Authenticity, storage, and legal import are all open. EMA duration for nausea is usually one week. Gastroparesis courses, where used at all, are specialist and off the simple lock. A hundred-count box already argues against the one-week sentence. See a GI clinic. Do not dose anonymous foil. Nausea role .

Creatinine is high. Still 10 mg three times daily?

Severe renal impairment stretched half-life from 7.4 to 20.8 hours in the monograph. Repeat-dose frequency should fall to once or twice daily and the dose may need a reduction. A single tablet is less the issue than a week of TID. Your prescriber owns that cut. We will not pick 10 mg versus 10 mg daily from an email creatinine.

Why link Walgreens if they do not sell Motilium?

The fill rail is a honesty device. Those are ordinary US pharmacy pages. The caption says this is not a routine US NDC and that we do not invent a coupon. Clicking a chain does not create a Motilium shelf. If a US pharmacist compounds or refuses, that is their licence talking. Juvia does not dispense and does not broker imports. Disclaimer .

Pediatric drop from a relative in Spain. Child is 8 and 24 kg. Convert the 10 mg tablet?

No. The 10 mg tablet lock is for people 12 and older who weigh at least 35 kg. A 292-child gastroenteritis study with 0.25 mg/kg suspension missed its primary endpoint. Kitchen conversion of an adult tablet is not a measuring device. If a licensed suspension exists in that clinic's country, they draw it. Electrolyte loss from vomiting plus a QT-active drug is a reason to rehydrate first and call a pediatrician, not to crush Motilium.

Grapefruit every breakfast. Hold the juice or hold the tablet?

Canadian patient pages list grapefruit juice with potent CYP3A4 inhibitors as a contraindicated partner. Hold the juice for the short Motilium week, or do not start the tablet. Do not split the difference with 'only a small glass.' If breakfast grapefruit is non-negotiable, pick a different antiemetic with the prescriber. The interaction is about raised domperidone levels and QT, not about breakfast politics.

Parkinson nausea on levodopa. Canadian cousin mailed Motilium. ECG first?

Nausea from some antiparkinson drugs is an authorised Canadian use inside the 30 mg/day ceiling. Age, other QT drugs, and electrolytes still apply. An ECG and a medicine reconciliation before the first 10 mg tablet is reasonable, especially over 60. Do not add a second peripheral dopamine blocker from a drawer. Import from a cousin is not a labelled US path and not a reason to skip the cardiac review. Your neurologist owns the combination.

Motilium 10 mg Reviews: Domperidone Not a US Pharmacy Fill

01Open: this 10 mg tablet is not a US retail NDC

Opened as a 10 mg Motilium letter with no US cash figure. QT and lactation sit in the annotation, not in a price cell.

US cash boards do not carry Motilium as a routine retail tablet. FDA has not approved domperidone for marketing. Compounded or imported stock is a clinician-and-regulator problem, not a coupon problem. This desk will not invent a dollar to look complete.

Health Canada still lists 10 mg tablets. EMA products remain on the market for nausea and vomiting after the 2014 dose-and-duration cut. Those are the sheets this letter annotates.

Nora Lindqvist opens motility mail on cardiac risk and on the missing US NDC, in that order. Dated 21 August 2026. Method: Open, Annotate, Countersign, Seal. [email protected]. Educational desk. No dispense.

Forum carts that price 'Motilium 10 mg x 100' are not a GoodRx line. Treat them as unverified import. Counterfeit antiemetics exist. We will not rank sellers.

If your US clinician is navigating an expanded-access or compounding path for a documented GI indication, that conversation stays in that clinic. The fill rail under this letter links ordinary US chains only to say they are not a Motilium aisle.

02What the Canadian monograph actually measured

A fasting two-way crossover in 24 healthy men compared a generic 10 mg tablet with Motilium 10 mg. Twenty-two completed the statistics. That study exists to show the generic matches the brand, not to give you a Tmax to time against a ferry ride.

Older high-dose kinetic work quoted peaks near 100 ng/mL after 60 mg. Modern labelling forbids that daily load. Do not resurrect 60 mg curves to justify a forum TID-plus-bedtime plan.

Because CYP3A4 is the main N-dealkylation path, a new azole in week one of Motilium is a stop, not a 'watch it.' Grapefruit juice sits on the same contraindication list in the patient pages.

Parkinson patients already take other dopamine-touching drugs. Adding domperidone for nausea can be labelled in Canada and still needs a reconciliation so two peripheral blockers do not stack by accident.

Half-life near 7 hours in healthy kidneys is why TID before meals is plausible for a week and implausible as a silent chronic. When the half-life stretches to 21 hours in severe renal disease, TID is the wrong clock.

03Peripheral D2, prolactin, and why milk is off-label

Domperidone blocks peripheral dopamine receptors in the gut and in the chemoreceptor trigger zone that sits outside a tight blood-brain barrier. That is why acute dystonia is less discussed than with metoclopramide, and why prolactin still rises.

Prolactinoma is a contraindication. So is any situation where pushing gut motility could harm: bleed, mechanical obstruction, perforation.

No regulator licenses Motilium to make milk. Health Canada has reviewed psychiatric withdrawal - insomnia, anxiety, depression - when high-dose or long lactation courses stop suddenly. Most of those cases sat above 30 mg/day and lasted over four weeks. LactMed notes typical study regimens of 10 mg three times daily for 4-10 days and no official galactagogue dose anywhere.

FDA has warned against imported or compounded domperidone for breastfeeding. InfantRisk and LactMed walk that warning. This desk will not provide a pumping protocol or a wean table for milk. QT and milk postscript is the short companion.

If a lactation specialist in a country where the drug is marketed still uses it off-label, that is their consent, ECG, and taper problem. It is not a US cash fill and not a Juvia coupon.

04QT, age over 60, and the 30 mg wall

Age over sixty raises the ventricular-arrhythmia signal in the epidemiology the SmPC quotes. Daily doses above 30 mg do the same. Known long QT, unstable electrolytes, bradycardia, and heart failure are contraindications.

A thorough QT study at 20 mg four times daily (80 mg/day) showed a mean QTc change versus placebo of 3.4 msec (90% CI 1.0-5.9) on day 4. That is below the usual 10 msec regulatory worry line and still not a free pass at labelled 30 mg in older or stacked patients. Post-marketing torsades reports exist, often with other risks piled on.

Stop the tablet and seek care for palpitations, syncope, or seizure. Do not 'finish the box' through a faint.

QT literacy on this site also lives in the vardenafil letter. Different molecule, same request: name the other QT drugs before you start. Do not stack Motilium with a PDE5 on a hunch.

Electrolytes after vomiting are part of the antiemetic visit. Hypokalaemia plus a QT drug is a classic ward mistake.

05The pediatric study that failed its primary endpoint

A multicentre, double-blind program put 292 children aged 6 months to 12 years on oral-rehydration therapy plus either domperidone suspension at 0.25 mg/kg up to three times daily (capped near 30 mg/day) or placebo, for up to 7 days. The SmPC says the study missed its primary efficacy objective. That is why the 10 mg tablet lock stays with adolescents who already weigh 35 kg, and why younger kids do not inherit an adult blister.

Parents sometimes hear 'Motilium drops' from an older relative. Liquid products that remain licensed in some markets come with a measuring device for a reason. Kitchen teaspoons and adult 10 mg tablets are not that device.

Prolactin rise in a child is not a harmless lab curiosity. Galactorrhoea or breast budding on a dopamine antagonist needs a stop and a review, not a dose increase for leftover nausea.

Cardiac risk language is not adults-only. Electrolyte loss from gastroenteritis plus a QT-active antiemetic is a bad pair at any age. Rehydrate first. Drug second, if at all, and only on a licensed pediatric indication.

This desk will not convert 10 mg tablets into a mg/kg liquid on the back of an envelope. If a Nordic clinic still uses a licensed suspension, they own the syringe marks.

06Nausea indication after the 2014 EMA cut

EMA cut the indication to nausea and vomiting. Older dyspepsia and reflux add-on uses were stripped in the referral. The adult oral dose became 10 mg up to three times daily, 30 mg/day maximum. Suppositories at 30 mg twice daily remain in some markets. Treatment should not normally last more than one week.

Adolescents 12 and over must also weigh 35 kg or more for the 10 mg tablet. Efficacy in younger children was not established in the later pediatric gastroenteritis program the SmPC cites. Weight-based 0.25 mg/kg oral liquid remains only where a licensed pediatric product still exists.

People older than 60 should speak with a clinician before Motilium. Epidemiology put higher ventricular-arrhythmia and sudden-death risk on age over 60, daily doses above 30 mg, and QT or CYP3A4 partners.

This is a short antiemetic, not a gastroparesis lifestyle drug. Longer off-label courses need a specialist who owns the QT screen and the stop date. Nausea-role postscript keeps the indication narrow.

Metoclopramide crosses into the CNS more readily and brings tardive risk on long use. It is not a silent Motilium substitute, and Motilium is not a silent metoclopramide substitute. Different labels, different neurologic and cardiac footprints.

07Before-meal timing and the one-week ceiling

Take the tablet before food if you can. Absorption delays when the dose follows a meal. Health Canada patient language still says 15-30 minutes before meals for the 10 mg TID schedule.

Missed a dose? Skip it. Resume the usual clock. Do not double. The Irish SmPC writes that in plain words and the desk keeps it.

Usually the maximum duration should not exceed one week. If nausea lasts longer, the problem is the diagnosis, not a second box of Motilium. Pregnancy, surgical abdomen, raised intracranial pressure, and drug toxicity do not wait on a prokinetic.

Orodispersible 10 mg Fastmelts dissolve on the tongue. Swallow tablets are the lock on this letter. Do not crush a film-coated tablet and call it a Fastmelt.

Severe renal impairment stretches half-life from about 7.4 hours to about 20.8 hours. Repeat-dose frequency falls to once or twice daily and the milligram may need a cut. Moderate or severe hepatic impairment is a contraindication, not a cautious start.

08Health Canada monograph versus FDA silence

Health Canada still markets ten-milligram tablets for GI symptoms, including nausea from some antiparkinson drugs. Maximum recommended daily dose for authorised uses is 30 mg. Lactation is not an authorised use there either.

Protein binding sits around 92-93% in the Canadian monograph. Oral levels in older high-dose work reached on the order of 100 ng/mL after 60 mg, a dose the modern ceiling no longer allows. CYP3A4 runs N-dealkylation; CYP3A4, CYP1A2, and CYP2E1 share aromatic hydroxylation.

FDA silence means no labelled US counselling sheet in the bottle. People who obtain tablets anyway miss the one-week and CYP3A4 sentences unless a clinician prints a foreign SmPC. That gap is a safety problem, not a pricing problem.

Personal import can bypass recall systems. A colour change between unregulated lots is not a brand story; it is an authenticity story. Photograph and stop until a pharmacist or clinician can name the manufacturer.

Swedish and other EU pharmacy supply, where the product is licensed, is a different legal object from a US mailbox blister. This desk will not map customs routes.

09CYP3A4 partners that close the letter

Ketoconazole and erythromycin close this letter. Potent CYP3A4 inhibitors are contraindicated whether or not they also prolong QT. The list on Canadian and EU sheets includes systemic azoles, several macrolides, HIV protease inhibitors, nefazodone, and grapefruit juice.

Ketoconazole interaction work is the historical reason the dose ceiling exists. The combination raised domperidone levels and QT together.

Moderate CYP3A4 inhibitors such as diltiazem and verapamil are 'not recommended' language, not a shrug. QT-prolonging partners are contraindicated except for a narrow apomorphine footnote on some EU texts that is irrelevant to a nausea burst.

Azithromycin appears on some patient lists as a macrolide to flag. When in doubt, hold Motilium during the antibiotic and ask the prescriber. Do not finish both boxes because they came the same week.

Reference centres on this site point at regulators, not at compounding pharmacies.

Stops the desk annotates before any 10 mg tablet

Potent CYP3A4 inhibitors: contraindicated (azoles, many macrolides, PIs, nefazodone, grapefruit)
QT-prolonging drugs: contraindicated (EU/HC sheets)
Moderate CYP3A4 inhibitors (diltiazem, verapamil): avoid
Known long QT, HF, bad electrolytes: contraindicated
Moderate or severe hepatic impairment: contraindicated

10What a compounding conversation is not

Compounding talk is a clinician decision in the jurisdiction that allows it. It is not a Juvia product, not a coupon, and not a lactation kit. FDA has told compounding pharmacies not to supply domperidone for breastfeeding.

If a US specialist is using a regulated research or import pathway for refractory GI disease, ask that clinic for the monitoring plan: ECG, electrolytes, interacting drugs, stop date. Bring that paper to any other prescriber you see that month.

Do not price-shop 'Motilium 10 mg' against metoclopramide 10 mg on a US cash board and call them equivalent. Different approvals, different neurologic risk, different cardiac footnotes.

Nora Lindqvist countersigns the educational file. Disclaimer applies. Method page if you want the four stamps without the drug.

Questions: [email protected]. We will send citations. We will not send a supplier.

11Missed dose, renal frequency, hepatic stop

Skip a missed tablet rather than doubling at the next meal. The nausea you are treating is not an excuse to stack 20 mg in one hour.

Severe renal impairment: keep the milligram conversation and cut frequency on repeat dosing. Little unchanged drug leaves in urine, so a single dose is less of a renal math problem than a week of TID.

Moderate or severe liver impairment: do not start. Mild impairment does not need a dose rewrite on the SmPC.

Hypersensitivity to domperidone or a Fastmelt excipient (aspartame on some ODTs) is a stop. Phenylketonuria matters for aspartame melts, not for every film-coated 10 mg tablet.

Parkinson disease nausea from dopaminergics is a labelled Canadian use in some monographs and still sits inside the 30 mg/day and QT rules. Do not add Motilium on top of other peripheral dopamine blockers without a reconciliation.

12Seal this Motilium letter without inventing a dollar

Seal this Motilium letter without inventing a dollar. 10 mg, before meals, up to TID, 30 mg/day, usually one week, QT and CYP3A4 as hard stops, milk as off-label everywhere.

US windows on the rail below are ordinary pharmacies. They are not a Motilium aisle. Each href is that chain only.

21 August 2026, Stockholm Letters desk. Educational annotation. No dispense.

Domperidone 10 mg (Motilium) is not a standard US pharmacy fill. Juvia does not invent a dollar. The letter files Health Canada and EMA labelling. Compounded or import paths are a clinician decision, not a coupon. Each href is that chain only. Juvia does not dispense.
Pharmacy	Strength / count	How the window works	Official page
Walgreens	10 mg tablet	Not a routine US retail NDC	Walgreens pharmacy
Meijer	10 mg tablet	No invented Motilium coupon	Meijer pharmacy
Safeway	10 mg tablet	Health Canada / EMA labels, not a US cash board	Safeway pharmacy
H-E-B	10 mg tablet	QT and milk notes still apply	H-E-B pharmacy

Sources and how this letter was sealed

EMA / CMDh 2014 domperidone referral: 10 mg up to TID, max 1 week, cardiac risk groups.
HPRA Motilium Fastmelts 10 mg SmPC: before meals, skip missed dose, hepatic contraindication, QT study 3.4 msec at 80 mg/day.
Health Canada domperidone product monograph: 10 mg TID, max 30 mg/day, 15-30 min before meals; t1/2 7.4 vs 20.8 h in severe renal impairment; CYP3A4; not authorised for lactation.
LactMed and InfantRisk: not FDA-approved; no licensed galactagogue dose; FDA warning on import/compounding for milk.
Health Canada SSR on psychiatric withdrawal after high-dose lactation taper.

Method in brief: open primary sources, annotate against the current FDA label, countersign by Dr. Nora Lindqvist, MD, then seal with a dated review. Full walk-through on the method page and editorial standards.

How to cite this page - Vancouver style

Juvia Pharma Despatch Desk. Motilium 10 mg sits on EU and Canadian labels, not a US cash board [Internet]. Stockholm: Juvia Pharma; 21 August 2026 [cited 2026 Aug 21]. Available from: https://juviapharma.com/letters/domperidone/